Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,864.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 28,625
  • Market Cap: £1,230.85m
  • RiskGrade: 128

Genus' porcine unit boosted by outbreak of African swine fever

By Iain Gilbert

Date: Thursday 14 Nov 2019

LONDON (ShareCast) - (Sharecast News) - Animal genetics firm Genus said its porcine and dairy and beef businesses grew during the four months ended 31 October on Thursday, with revenues and adjusted operating profits coming in higher year-on-year.
Genus said pork prices in China had continued to increase as a result of the impact of African swine fever throughout the nation, raising demand for its genetics.

The FTSE 250-listed firm also said royalty revenues in PIC, its porcine unit, continued to grow across all regions during the period.

"While we continue to closely monitor its spread to the Philippines and other parts of Southeast Asia, we expect PIC Asia to increase profits in FY20 compared with the prior year," said Genus.

Adjusted profit before tax showed "good growth" from the prior year, while net debt at the end of October was in line with expectations and reflected normal seasonal trends.

Research and development investment increased, primarily from investment in elite genetic production sites and populations.

Looking forward, Genus said it anticipates continued strategic and financial progress, with the group anticipating that it will perform in line with growth expectations in 2020.

As of 0925 BST, Genus shares had inched ahead 0.37% to 3,157.58p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,864.00p
Change Today -4.00p
% Change -0.21 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 28,625
Shares Issued 66.03m
Market Cap £1,230.85m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
10:59 12 @ 1,864.00p
10:57 900 @ 1,863.35p
10:57 0 @ 1,856.00p
10:41 90 @ 1,864.00p
10:41 42 @ 1,864.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page